# Autoimmune Cytopenia and BcR Inhibitors

> **NCT03469895** · — · UNKNOWN · sponsor: **Institut Paoli-Calmettes** · enrollment: 40 (actual)

## Conditions studied

- Autoimmune Cytopenia Associated With Chronic Lymphocytic Leukemia

## Interventions

- **DRUG:** ibrutinib ou idelalisib

## Key facts

- **NCT ID:** NCT03469895
- **Lead sponsor:** Institut Paoli-Calmettes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-21
- **Primary completion:** 2018-07
- **Final completion:** 2018-07
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2018-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03469895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03469895, "Autoimmune Cytopenia and BcR Inhibitors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03469895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*